Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
- Disease/Condition
- Chronic Pain
- Drug/Device/Intervention
- Inflammation Support Formula
- Study type
- Interventional
- Intervention type
- dietary supplement
- Primary sponsor
- Ethos Research & Development
- Location
- Newport, United States of America
- Phase
- Phase 2
- Start date
- Feb 01, 2024
- End date
- Jul 30, 2025
- Enrollment
- 75 participants
Quantitative urine biomarker levels.,Quality-of-life measures.,Quality-of-life measures.
The goal of this study is to use pain-specific urine biomarkers to evaluate how daily
 nutritional supplementation with biomarker guided formulas effect, quality of life and
 urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided
 supplementation on pain specific biomarkers through changes in urinary biomarker scores may
 solidify the necessity for identifying deficiencies to create an individualized treatment
 plan for pain patients. This study aims to evaluate the effect of biomarker-guided
 supplementation on the three categories of urinary biomarkers using targeted ingredients
 specifically designed for oxidative stress, inflammation, and nerve health. This study
 provides subjects with one of three nutritional supplement formulas based on their specific
 urinary biomarker test results and assesses changes in their urinary biomarker levels and
 their quality of life as it relates to their pain over a 3-month period.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06247813
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06247813 through Pure Global AI's free database. This Phase 2 trial is sponsored by Ethos Research & Development and is currently Recruiting. The study focuses on Chronic Pain. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.